Form 144: Morgan Stanley Smith Barney lists 24,225 EVMN shares

Morgan Stanley Smith Barney LLC submitted a Form 144 notice relating to EVMN securities as of 06/01/2026.

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC submitted a Form 144 notice relating to EVMN securities as of 06/01/2026. The filing lists 24,225 shares (aggregate line), including sales tied to Pre-IPO purchases: 13,760 shares dated 06/22/2020 and 10,465 shares dated 12/28/2020.

Key Figures

Filing date: 06/01/2026 Shares reported (aggregate line): 24,225 shares Pre-IPO sale entry: 13,760 shares +2 more

5 metrics

Filing date 06/01/2026 Form 144 submission date

Shares reported (aggregate line) 24,225 shares Aggregate shares line in the filing excerpt

Pre-IPO sale entry 13,760 shares Pre-IPO purchase of common shares dated 06/22/2020

Pre-IPO sale entry 10,465 shares Pre-IPO purchase of common shares dated 12/28/2020

Numeric line present 562,746.75 Unlabeled numeric value appearing in excerpt

Key Terms

Form 144, Pre-IPO Purchase of Common Shares, Issuer

3 terms

Form 144 regulatory

"144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Pre-IPO Purchase of Common Shares financial

"Pre-IPO Purchase of Common Shares | Issuer"

Issuer financial

"Pre-IPO Purchase of Common Shares | Issuer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filed by Morgan Stanley Smith Barney say for EVMN?

The Form 144 lists a reported quantity of 24,225 shares tied to the filer, with specific Pre-IPO purchase sale entries of 13,760 and 10,465 shares dated 06/22/2020 and 12/28/2020 respectively.

Who is the filer on the EVMN Form 144 and what role is shown?

The filing names Morgan Stanley Smith Barney LLC at New York Plaza as the filer. The entry identifies the transactions as related to Pre-IPO purchases and lists the Issuer as the source of those securities.

What dates are associated with the securities reported in the EVMN Form 144?

The Form 144 shows a filing/reference date of 06/01/2026 and records Pre-IPO purchase entries dated 06/22/2020 (13,760 shares) and 12/28/2020 (10,465 shares).

Does the EVMN Form 144 show proceeds or pricing information?

The excerpt includes a numeric line (562,746.75) but does not label it explicitly as proceeds or price per share. The filing text provided does not attach a clear proceeds label to that figure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/01/2026 - 04:46 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001620548
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Evommune, Inc.
SEC File Number	001-42938
Address of Issuer	1891 Page Mill Road Palo Alto CALIFORNIA 94304
Phone	925-247-4481
Name of Person for Whose Account the Securities are To Be Sold	LUIS PENA
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	24225	562746.75	36018372	06/01/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/22/2020	Pre-IPO Purchase of Common Shares	Issuer			13760	06/22/2020	Cash
Common	12/28/2020	Pre-IPO Purchase of Common Shares	Issuer			10465	12/28/2020	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	06/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/02/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Pena Luis C
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)